MCS-18

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMCS-18
Drug Alias NameMCS-18
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionVanilloid receptor antagonists
TargetsTransient receptor potential cation channel subfamily V member 1
Therapy Area/IndicationsMusculoskeletal Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSinatur
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSinatur
Active IndicationsN/A
Inactive IndicationsMusculoskeletal Pain

Other Information

ATC CodeN/A
Related LinksN/A